Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent
Crossref DOI link: https://doi.org/10.1186/s40203-015-0010-5
Published Online: 2015-06-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
El-Saadi, Madison Wynne
Williams-Hart, Tara
Salvatore, Brian A
Mahdavian, Elahe
License valid from 2015-06-04
Article History
Received: 28 January 2015
Accepted: 13 May 2015
First Online: 4 June 2015